Chemours/$CC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Chemours
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Ticker
$CC
Sector
Primary listing
NYSE
Employees
6,000
Headquarters
Website
Chemours Metrics
BasicAdvanced
$1.9B
-
-$2.13
1.58
$0.68
2.75%
Price and volume
Market cap
$1.9B
Beta
1.58
52-week high
$21.72
52-week low
$9.13
Average daily volume
3.2M
Dividend rate
$0.68
Financial strength
Current ratio
1.706
Quick ratio
0.83
Long term debt to equity
1,433.667
Total debt to equity
1,473
Interest coverage (TTM)
1.26%
Profitability
EBITDA (TTM)
659
Gross margin (TTM)
17.54%
Net profit margin (TTM)
-5.48%
Operating margin (TTM)
5.82%
Effective tax rate (TTM)
-68.78%
Revenue per employee (TTM)
$970,000
Management effectiveness
Return on assets (TTM)
2.83%
Return on equity (TTM)
-66.53%
Valuation
Price to revenue (TTM)
0.328
Price to book
6.41
Price to tangible book (TTM)
7.64
Price to free cash flow (TTM)
-159.459
Free cash flow yield (TTM)
-0.63%
Free cash flow per share (TTM)
-0.08
Dividend yield (TTM)
5.29%
Forward dividend yield
2.75%
Growth
Revenue change (TTM)
0.03%
Earnings per share change (TTM)
-617.44%
3-year revenue growth (CAGR)
-6.02%
10-year revenue growth (CAGR)
-0.12%
3-year earnings per share growth (CAGR)
-27.55%
10-year earnings per share growth (CAGR)
17.80%
3-year dividend per share growth (CAGR)
-12.28%
What the Analysts think about Chemours
Analyst ratings (Buy, Hold, Sell) for Chemours stock.
Bulls say / Bears say
Thermal & Specialized Solutions segment net sales increased 20% to $560 million in Q3 2025, driven by an 80% rise in Opteon™ refrigerant volumes and a 40% boost in adjusted EBITDA, with margins expanding five percentage points to 35% (Business Wire)
Chemours returned to profitability in Q3 2025, posting net income of $60 million (EPS $0.40) compared to a $32 million loss a year earlier, reflecting operational improvements and cost controls (Business Wire)
A federal appeals court upheld the EPA’s HFC phase-out rule under the AIM Act, reinforcing regulatory support for low-GWP Opteon™ refrigerants and supporting Chemours’ market leadership in sustainable cooling solutions (Reuters)
Titanium Technologies segment adjusted EBITDA fell 68% to $25 million in Q3 2025, with margins dropping to just 4% due to weaker TiO₂ pricing and $11 million in operational disruption costs (Business Wire)
Chemours faces a present-value liability of about $250 million for PFAS contamination under a New Jersey settlement, representing half of a $500 million obligation shared with DuPont and Corteva over 25 years (Reuters)
As of June 30, 2025, Chemours reported net debt of $3.7 billion and a net leverage ratio of 4.7× EBITDA, limiting financial flexibility amid ongoing operational challenges (Business Wire)
Data summarised monthly by Lightyear AI. Last updated on 9 Nov 2025.
Chemours Financial Performance
Revenues and expenses
Chemours Earnings Performance
Company profitability
Chemours News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Chemours stock?
Chemours (CC) has a market cap of $1.9B as of November 12, 2025.
What is the P/E ratio for Chemours stock?
The price to earnings (P/E) ratio for Chemours (CC) stock is 0 as of November 12, 2025.
Does Chemours stock pay dividends?
Yes, the Chemours (CC) stock pays dividends to shareholders. As of November 12, 2025, the dividend rate is $0.675 and the yield is 2.75%. Chemours has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Chemours dividend payment date?
The next Chemours (CC) dividend payment is scheduled for December 15, 2025.
What is the beta indicator for Chemours?
Chemours (CC) has a beta rating of 1.58. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.